Movement Alert|Accenture Rises 3.05% in Regular Trading, Shares Rebound After Digesting IBM Earnings Shock

Market Focus07-15

On July 15, Accenture rose 3.05% in regular trading, trading at approximately $139.00/share, with turnover of $233 million. The stock rebounded as the market digested the prior session's sector-wide selloff triggered by IBM's earnings miss.

On July 14, IBM reported preliminary Q2 results that fell sharply below expectations, sending its shares down over 23% and dragging IT consulting peers lower. Accenture dropped as much as 4.83% that day to $133.88, alongside declines of roughly 4.5% in ServiceNow and SAP. With the initial shock absorbed, Accenture's stock underwent a technical recovery on July 15.

Fundamental support remains in place. Accenture's subsidiary completed a five-tranche notes offering totaling approximately $5 billion with estimated net proceeds of $4.98 billion, fully and unconditionally guaranteed by the parent company. Additionally, the company recently signed a contract worth approximately 200 million euros with the NATO Communications and Information Agency to deliver its Protected Business Network program over the next seven years, reinforcing a constructive order pipeline.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment